Cargando…

Efficacy of N-Acetylcysteine in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis

There are a number of conflicting reports describing the clinical outcomes of using N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis. We have, therefore, performed a meta-analysis to evaluate the efficacy of N-acetylcysteine, compared with control, for the treatment of idiopathic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Tong, Liu, Jing, Zhao, De Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	6700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902516/ https://www.ncbi.nlm.nih.gov/pubmed/27175674 http://dx.doi.org/10.1097/MD.0000000000003629

Ejemplares similares

Efficacy of exercise in patients with pulmonary fibrosis: A systematic review and meta-analysis
por: Gao, Yan, et al.
Publicado: (2022)

Chinese herbal medicines for the treatment of cough in idiopathic pulmonary fibrosis: A protocol for systematic review and meta-analysis
por: Xiao, Siyao, et al.
Publicado: (2020)

Impact of serum SP-A and SP-D levels on comparison and prognosis of idiopathic pulmonary fibrosis: A systematic review and meta-analysis
por: Wang, Kai, et al.
Publicado: (2017)

Increased frequency of angiotensin converting enzyme D allele in Chinese Han patients with idiopathic pulmonary fibrosis: A systematic review and meta-analysis
por: Wu, Xiaozheng, et al.
Publicado: (2022)

The clinical efficacy of a mixture of ivy leaf extract and coptidis rhizome in patients with idiopathic pulmonary fibrosis
por: Lee, Jae Ha, et al.
Publicado: (2023)

Traditional Chinese medicine for the treatment of pulmonary fibrosis: A protocol for systematic review and meta-analysis of overview
por: Li, Li-Juan, et al.
Publicado: (2020)

Double-Blind Randomized Trial of Pirfenidone in Chinese Idiopathic Pulmonary Fibrosis Patients
por: Huang, Hui, et al.
Publicado: (2015)

ANCA-associated vasculitis in idiopathic pulmonary fibrosis: A case report and brief review of the literature
por: Traila, Daniel, et al.
Publicado: (2022)

Prognostic significance of pulmonary hypertension in patients with cystic fibrosis: A systematic review and meta-analysis
por: Li, Diandian, et al.
Publicado: (2018)

Using bioinformatics approach identifies key genes and pathways in idiopathic pulmonary fibrosis
por: Xu, Zhongbo, et al.
Publicado: (2020)

Right ventricular contractility decreases during exercise in patients with non-advanced idiopathic pulmonary fibrosis
por: Cobra, Sandra de Barros, et al.
Publicado: (2021)

A score without diffusion capacity of the lung for carbon monoxide for estimating survival in idiopathic pulmonary fibrosis
por: Fukuda, Cesar Yoshito, et al.
Publicado: (2020)

A retrospective study of in-hospital mortality in patients with idiopathic pulmonary fibrosis between 2015 and 2018
por: Durheim, Michael T., et al.
Publicado: (2020)

A novel prognostic index based on the analysis of glycolysis-related genes in idiopathic pulmonary fibrosis
por: Li, Yu, et al.
Publicado: (2023)

Network pharmacology and molecular docking to explore the pharmacological mechanism of Yifei Tongluo granules in treating idiopathic pulmonary fibrosis: A review
por: Hou, Yuan, et al.
Publicado: (2023)

CT-Base Pulmonary Artery Measurementin the Detection of Pulmonary Hypertension: A Meta-Analysis and Systematic Review
por: Shen, Yongchun, et al.
Publicado: (2014)

Tonsillar Metastasis of Small Cell Lung Cancer in a Patient With Idiopathic Pulmonary Fibrosis: A Case Report
por: Kim, Eo Jin, et al.
Publicado: (2015)

Suspected accelerated disease progression after discontinuation of nintedanib in patients with idiopathic pulmonary fibrosis: Two case reports
por: Okamori, Satoshi, et al.
Publicado: (2017)

Association Between the MUC5B Promoter Polymorphism rs35705950 and Idiopathic Pulmonary Fibrosis: A Meta-analysis and Trial Sequential Analysis in Caucasian and Asian Populations
por: Zhu, Qing-Qing, et al.
Publicado: (2015)

Efficacy and safety of Chuankezhi injection in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis protocol
por: Zhou, Zhihui, et al.
Publicado: (2020)

Efficacy and safety of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis caused by novel coronavirus disease: A protocol for Bayesian network meta-analysis
por: Li, Feiran, et al.
Publicado: (2021)

Efficacy and safety of acupoint autohemotherapy in treating stable chronic obstructive pulmonary disease: Protocol for a systematic review and meta-analysis
por: Hong, Haidu, et al.
Publicado: (2019)

Experience of N-acetylcysteine airway management in the successful treatment of one case of critical condition with COVID-19: A case report
por: Liu, Yan, et al.
Publicado: (2020)

Clinical characteristics of non-idiopathic pulmonary fibrosis, progressive fibrosing interstitial lung diseases: A single-center retrospective study
por: Komatsu, Masamichi, et al.
Publicado: (2021)

Diagnostic finding on high-resolution computed tomography (HRCT) predicts a good response to pirfenidone in patients with idiopathic pulmonary fibrosis
por: Ma, Miao, et al.
Publicado: (2023)

Early diagnosis for pulmonary embolism: A systematic review and meta-analysis
por: Ma, Minjun, et al.
Publicado: (2023)

Safety and efficacy of acupuncture for the treatment of chronic obstructive pulmonary disease: A systematic review protocol
por: Yu, Mingxia, et al.
Publicado: (2019)

Comparisons of Prognosis between Surgically and Clinically Diagnosed Idiopathic Pulmonary Fibrosis Using Gap Model: A Korean National Cohort Study
por: Lee, Sang Hoon, et al.
Publicado: (2016)

Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administration
por: Ikeda, Satoshi, et al.
Publicado: (2022)

Efficacy and safety of N-acetylcysteine therapy for idiopathic pulmonary fibrosis: An updated systematic review and meta-analysis
por: Feng, Fanchao, et al.
Publicado: (2019)

The efficacy and safety of osimertinib in treating nonsmall cell lung cancer: A PRISMA-compliant systematic review and meta-analysis
por: Liu, Jing, et al.
Publicado: (2020)

Efficacy and safety of riociguat in the treatment of chronic thromboembolic pulmonary arterial hypertension: A meta-analysis
por: Ying, Miaofa, et al.
Publicado: (2021)

Efficacy and safety of Chinese patent medicine injection for COVID-19: A protocol for systematic review and meta-analysis
por: Lu, Meiqi, et al.
Publicado: (2020)

Efficacy and safety of erlotinib combined with bevacizumab in the treatment of non-small cell lung cancer: A systematic review and meta-analysis
por: Zhou, Kenan, et al.
Publicado: (2020)

Association of matrix metalloproteinase-12 polymorphisms with chronic obstructive pulmonary disease risk: A protocol for systematic review and meta analysis
por: Yang, Hongjing, et al.
Publicado: (2020)

The efficacy and safety of long-term add-on treatment of azithromycin in asthma: A systematic review and meta-analysis
por: Wang, Xiaohu, et al.
Publicado: (2019)

Efficacy and safety of methylprednisolone against acute respiratory distress syndrome: A systematic review and meta-analysis
por: Lv, Hai, et al.
Publicado: (2021)

Efficacy and safety of Chinese medicine for obstructive sleep apnea: A protocol for systematic review and meta-analysis
por: Bao, Jun-Li, et al.
Publicado: (2021)

Effects of Jianpi Yiqi method for chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis
por: Wang, Yuxi, et al.
Publicado: (2020)

Effect of myrtol on chronic bronchitis or chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis
por: Liu, Liyun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gic9m1ke3k7iasr1ba8e4tc0o6